PA-BENTLEY-SYSTEMS
Bentley Systems, Incorporated, a leading global provider of comprehensive software solutions for advancing infrastructure , today announced the acquisition of Plaxis , the leading provider of geotechnical software, based in Delft, Netherlands, and the agreement to acquire soil engineering software provider SoilVision , based in Saskatchewan, Canada. The acquisitions, with Bentley’s market-leading borehole reporting and data management software gINT, serve to make Bentley a complete source for geotechnical professionals “going digital.” Finally, BIM advancements can be extended to the essential subsurface engineering of every infrastructure project.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180425006935/en/
Projects necessarily begin with geotechnical surveys and sampling, captured with gINT for versatile documentation and reporting. Next, professionals perform engineering related to soil properties, soil behavior, and groundwater flow using SoilVision’s SVOFFICE applications, supplemented by Plaxis’ offerings. Then soil-structure interaction is analyzed through Plaxis ’ design, simulation, and engineering software (e.g. PLAXIS 2D, PLAXIS 3D).
The new opportunity, by way of digital workflows enabled through Bentley’s comprehensive modeling environment, is for geotechnical applications to be integrated with Bentley’s structural applications (such as STAAD, RAM, and SACS) for unprecedented geo-structural engineering performance. As changes may occur in owner requirements, structural strategies, or site conditions (continuously surveyed through UAVs and Bentley’s ContextCapture for reality modeling), geotechnical analysis could be continuously applied for improved outcomes, as managed through ProjectWise collaboration services.
For today’s infrastructure demands, geotechnical considerations are coming to the fore. Urbanization, for instance, drives growth both vertically and underground, with emphasis on the capacity of foundations and tunnels. And new infrastructure projects of every type depend upon constructed dams, embankments, dikes, levees, and reservoirs to improve their resilience. Moreover, new asset types such as offshore wind turbine structures require new geotechnical analysis capabilities, in this case to be accomplished with Plaxis’ forthcoming MoDeTo software.
Because infrastructure assets are crucially linked to subsurface environs, they are vulnerable to geo-environmental risks including seismic activity, subsidence, and weather impacts. Leveraging new digital workflows which incorporate real-time monitoring and analytics during infrastructure operations, geotechnical professionals can play the increasingly valuable role they deserve in achieving geo-environmental resilience.
Bentley Systems CEO, Greg Bentley said, “My colleagues and I welcome our new teams from Plaxis and SoilVision, which have in common a zeal for applying science for better engineering practice. Dr. Ronald Brinkgreve from Plaxis and Dr. Murray Fredlund, founder of SoilVision , exemplify this. I believe that every geotechnical engineer has benefitted from Plaxis’ continuous advancement, in scope and quality, of tools for their discipline to add value. With a professional and dedicated management team led by Jan-Willem Koutstaal, Plaxis has become one of the most successful software businesses I have ever seen.”
Bentley added, “While most infrastructure engineering disciplines converged around intuitive 3D models, geotechnical applications seem to have followed a less graphically intensive development path, and so have remained isolated from cross-discipline workflows. This ‘disconnected’ mindset prevailed even while Plaxis , SoilVision , and gINT mainstreamed 3D innovations. Our BIM platform’s comprehensive modeling environment will finally embrace the geotechnical profession in digital workflows for every infrastructure project and asset.”
Tony O’Brien, global practice leader for geotechnics for Mott MacDonald, said, “PLAXIS is one of our core analysis tools being used across our global geotechnics practice. When used by experienced specialists, PLAXIS can analyze many of our most complex ground-structure interaction problems. In Bentley’s hands, we have high expectations that we can accomplish more through digital workflows made possible through integration of PLAXIS technology with Bentley’s comprehensive modeling environment—workflows that are compatible with Mott MacDonald’s commitment to connected thinking and solving complex infrastructure challenges.”
About Plaxis
Plaxis is a global market leader in geotechnical engineering software based on the finite element method, offering its applications to users in more than 100 countries worldwide. With a well-established reputation as the industry standard for geotechnical design, Plaxis software serves project owners, contractors, and consultants in civil engineering, oil and gas, offshore industries, and governmental organizations. www.plaxis.com
About SoilVision
Founded in 1997, SoilVision has championed 3D conceptual design and analysis of slope stability, groundwater flow, stress/deformation, contaminant transport, thermal flows in saturated/unsaturated soils, and coupled processes for geotechnical engineers and hydrogeologists. The software solves complex problems by performing numerical modeling and analysis of earth structures in the areas of soil and rock slope stability of earth dams, open pits, levees, embankments, and retaining walls. The software has been utilized for basic designs as well as advanced unsaturated analysis. The software is utilized extensively in the mining industry for the design and evaluation of large engineered earth structures. www.soilvision.com
About Bentley Systems
Bentley Systems is a global leader in providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing the design, construction, and operations of infrastructure. Bentley users leverage information mobility across disciplines and throughout the infrastructure lifecycle to deliver better-performing projects and assets. Bentley solutions encompass MicroStation applications for information modeling , ProjectWise collaboration services to deliver integrated projects , and AssetWise operations services to achieve intelligent infrastructure – complemented by comprehensive managed services offered through customized Success Plans.
Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, more than $700 million in annual revenues, and since 2012 has invested more than $1 billion in research, development, and acquisitions. www.bentley.com
Related Images:
PLAXIS
3D
Caption:
PLAXIS 3D performs three-dimensional
analysis of deformation, soil-structure interaction, and stability in
geotechnical engineering and rock mechanics.
SoilVision
Caption:
SoilVision applications provide capabilities for engineering related to
soil properties, soil behavior, and groundwater flow.
##
Bentley, the “B” Bentley logo, AssetWise, ContextCapture, gINT, MicroStation, ProjectWise, RAM, SACS, and STAAD are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180425006935/en/
Contact:
Bentley Systems
Press:
Jennifer Maguire, +1 610 458 2695
jennifer.maguire@bentley.com
Follow
us on Twitter:
@BentleySystems
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
